Tyrogenex
Innovative biotech solutions for solid tumors through advanced multi-kinase angiogenesis inhibition.
General Information
BounceWatch is an independent company data service, not affiliated with Tyrogenex. To contact Tyrogenex, visit tyrogenex.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Tyrogenex compare?
A PDF of Tyrogenex and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Tyrogenex soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Tyrogenex
Taxonomy: Biotech, Cancer Therapeutics, Multi-Kinase Angiogenesis Inhibitors, Solid Tumor Treatment, VEGFR/PDGFR Inhibitor, Biotechnology Research, Drug Development, X-82, Tyrogenex Inc., Xcovery LLC, West Palm Beach, Innovation, Cancer Research, Medical Technology
Funding Rounds & Investors (5)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $543.95K | - |
|
26 Feb 2016 |
| Series D | $15.00M | 1 |
|
19 Jun 2014 |
| Debt Financing | $3.29M | - |
|
10 Apr 2014 |
| Venture Round | $1.59M | - |
|
05 Apr 2012 |
| Series A | $970.00K | - |
|
14 Dec 2011 |
Tyrogenex Alternatives & Competitors
View All Alternatives
A clinical stage biopharmaceutical company designing precise cancer therapeutics to address unmet me...
Developing precision small molecules to combat hard-to-treat tumors.
Developing a new class of ADCs based on NMT inhibition to treat cancer
FAQ About Tyrogenex
Source: BounceWatch company record for Tyrogenex, https://bouncewatch.com/company/tyrogenex, updated 27 December 2024. When citing, please name BounceWatch and link this page.
